tiprankstipranks
Bristol-Myers Squibb (BMY)
NYSE:BMY
US Market
BMY
Bristol-Myers Squibb
RESEARCH TOOLSreports
Want to see BMY full AI Analyst Report?

Bristol-Myers Squibb (BMY) Stock Forecast & Price Target

12,136 Followers
See the Price Targets and Ratings of:

BMY Analyst Ratings

Moderate Buy
21Ratings
Moderate Buy
9 Buy
11 Hold
1 Sell
Based on 21 analysts giving stock ratings to
Bristol-Myers
Squibb
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BMY Stock 12 Month Forecast

Average Price Target

$66.30
▲(2.44% Upside)
Based on 21 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target is $66.30 with a high forecast of $80.00 and a low forecast of $40.00. The average price target represents a 2.44% change from the last price of $64.72.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"39":"$39","60":"$60","81":"$81","49.5":"$49.5","70.5":"$70.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$80.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":66.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$66.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[39,49.5,60,70.5,81],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.31,66.44,67.57000000000001,68.7,69.83,70.96000000000001,72.09,73.22,74.35,75.48,76.61,77.74000000000001,78.87,{"y":80,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.31,65.38615384615385,65.46230769230769,65.53846153846153,65.61461538461539,65.69076923076923,65.76692307692308,65.84307692307692,65.91923076923077,65.99538461538461,66.07153846153847,66.14769230769231,66.22384615384615,{"y":66.3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,65.31,63.363076923076925,61.41615384615385,59.46923076923077,57.52230769230769,55.575384615384614,53.628461538461536,51.681538461538466,49.73461538461538,47.78769230769231,45.840769230769226,43.893846153846155,41.94692307692308,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":42.204,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 45, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.019,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 39, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.257,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 42, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.564,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 43, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.572,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 50, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.176,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 37, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.702,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 37, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.015,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.417,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.57,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.336,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.81,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.31,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$80.00Average Price Target$66.30Lowest Price Target$40.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Argus Research Analyst forecast on BMY
Jasper Hellweg
Argus Research
Argus Research
$75
Buy
15.88%
Upside
Upgraded
08/05/26
Bristol Myers upgraded to Buy from Hold at ArgusBristol Myers upgraded to Buy from Hold at Argus
RBC Capital Analyst forecast on BMY
Trung Huynh
RBC Capital
RBC Capital
$64
Hold
-1.11%
Downside
Reiterated
08/04/26
Bristol-Myers Squibb (BMY) Gets a Hold from RBC Capital
J.P. Morgan Analyst forecast on BMY
Chris Schott
J.P. Morgan
J.P. Morgan
$73
Buy
12.79%
Upside
Reiterated
08/04/26
Bristol-Myers Squibb (BMY) Gets a Buy from J.P. Morgan
Bank of America Securities Analyst forecast on BMY
Jason Gerberry
Bank of America Securities
Bank of America Securities
$71
Buy
9.70%
Upside
Reiterated
08/03/26
Analysts' Top Healthcare Picks: Alignment Healthcare (ALHC), Bristol-Myers Squibb (BMY)
Citi Analyst forecast on BMY
Geoff Meacham
Citi
Citi
$66→$70
Hold
8.16%
Upside
Reiterated
08/03/26
Bristol Myers price target raised to $70 from $66 at CitiBristol Myers price target raised to $70 from $66 at Citi
William Blair Analyst forecast on BMY
Matt Phipps
William Blair
William Blair
―
Hold
―
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY) and Teleflex (NYSE: TFX)
Berenberg Bank Analyst forecast on BMY
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
$60→$65
Hold
0.43%
Upside
Reiterated
08/03/26
Berenberg Bank Remains a Hold on Bristol-Myers Squibb (BMY)
Guggenheim Analyst forecast on BMY
Seamus Fernandez
Guggenheim
Guggenheim
$72→$75
Buy
15.88%
Upside
Reiterated
07/31/26
Bristol Myers price target raised to $75 from $72 at GuggenheimBristol Myers price target raised to $75 from $72 at Guggenheim
Truist Financial Analyst forecast on BMY
Srikripa Devarakonda
Truist Financial
Truist Financial
$65→$70
Buy
8.16%
Upside
Reiterated
07/31/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (NASDAQ: ILMN), Dyne Therapeutics (NASDAQ: DYN) and Bristol-Myers Squibb (NYSE: BMY)
Morgan Stanley Analyst forecast on BMY
Terence Flynn
Morgan Stanley
Morgan Stanley
$40
Sell
-38.20%
Downside
Reiterated
07/31/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), Neurocrine (NASDAQ: NBIX) and Genmab (NASDAQ: GMAB)
Wells Fargo Analyst forecast on BMY
Mohit Bansal
Wells Fargo
Wells Fargo
$60→$65
Hold
0.43%
Upside
Assigned
07/31/26
Bristol Myers price target raised to $65 from $60 at Wells FargoBristol Myers price target raised to $65 from $60 at Wells Fargo
Scotiabank Analyst forecast on BMY
Louise Chen
Scotiabank
Scotiabank
$60
Hold
-7.29%
Downside
Reiterated
07/31/26
Scotiabank Keeps Their Hold Rating on Bristol-Myers Squibb (BMY)
UBS Analyst forecast on BMY
Michael Yee
UBS
UBS
$70→$80
Buy
23.61%
Upside
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Bristol-Myers Squibb (NYSE: BMY) and Stryker (NYSE: SYK)
Barclays Analyst forecast on BMY
Emily Field
Barclays
Barclays
$75
Buy
15.88%
Upside
Reiterated
07/31/26
Barclays Sticks to Their Buy Rating for Bristol-Myers Squibb (BMY)
Cantor Fitzgerald Analyst forecast on BMY
Carter Gould
Cantor Fitzgerald
Cantor Fitzgerald
$59
Hold
-8.84%
Downside
Reiterated
07/30/26
Bristol-Myers Squibb (BMY) Receives a Hold from Cantor Fitzgerald
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Argus Research Analyst forecast on BMY
Jasper Hellweg
Argus Research
Argus Research
$75
Buy
15.88%
Upside
Upgraded
08/05/26
Bristol Myers upgraded to Buy from Hold at ArgusBristol Myers upgraded to Buy from Hold at Argus
RBC Capital Analyst forecast on BMY
Trung Huynh
RBC Capital
RBC Capital
$64
Hold
-1.11%
Downside
Reiterated
08/04/26
Bristol-Myers Squibb (BMY) Gets a Hold from RBC Capital
J.P. Morgan Analyst forecast on BMY
Chris Schott
J.P. Morgan
J.P. Morgan
$73
Buy
12.79%
Upside
Reiterated
08/04/26
Bristol-Myers Squibb (BMY) Gets a Buy from J.P. Morgan
Bank of America Securities Analyst forecast on BMY
Jason Gerberry
Bank of America Securities
Bank of America Securities
$71
Buy
9.70%
Upside
Reiterated
08/03/26
Analysts' Top Healthcare Picks: Alignment Healthcare (ALHC), Bristol-Myers Squibb (BMY)
Citi Analyst forecast on BMY
Geoff Meacham
Citi
Citi
$66→$70
Hold
8.16%
Upside
Reiterated
08/03/26
Bristol Myers price target raised to $70 from $66 at CitiBristol Myers price target raised to $70 from $66 at Citi
William Blair Analyst forecast on BMY
Matt Phipps
William Blair
William Blair
―
Hold
―
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY) and Teleflex (NYSE: TFX)
Berenberg Bank Analyst forecast on BMY
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
$60→$65
Hold
0.43%
Upside
Reiterated
08/03/26
Berenberg Bank Remains a Hold on Bristol-Myers Squibb (BMY)
Guggenheim Analyst forecast on BMY
Seamus Fernandez
Guggenheim
Guggenheim
$72→$75
Buy
15.88%
Upside
Reiterated
07/31/26
Bristol Myers price target raised to $75 from $72 at GuggenheimBristol Myers price target raised to $75 from $72 at Guggenheim
Truist Financial Analyst forecast on BMY
Srikripa Devarakonda
Truist Financial
Truist Financial
$65→$70
Buy
8.16%
Upside
Reiterated
07/31/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (NASDAQ: ILMN), Dyne Therapeutics (NASDAQ: DYN) and Bristol-Myers Squibb (NYSE: BMY)
Morgan Stanley Analyst forecast on BMY
Terence Flynn
Morgan Stanley
Morgan Stanley
$40
Sell
-38.20%
Downside
Reiterated
07/31/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), Neurocrine (NASDAQ: NBIX) and Genmab (NASDAQ: GMAB)
Wells Fargo Analyst forecast on BMY
Mohit Bansal
Wells Fargo
Wells Fargo
$60→$65
Hold
0.43%
Upside
Assigned
07/31/26
Bristol Myers price target raised to $65 from $60 at Wells FargoBristol Myers price target raised to $65 from $60 at Wells Fargo
Scotiabank Analyst forecast on BMY
Louise Chen
Scotiabank
Scotiabank
$60
Hold
-7.29%
Downside
Reiterated
07/31/26
Scotiabank Keeps Their Hold Rating on Bristol-Myers Squibb (BMY)
UBS Analyst forecast on BMY
Michael Yee
UBS
UBS
$70→$80
Buy
23.61%
Upside
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Bristol-Myers Squibb (NYSE: BMY) and Stryker (NYSE: SYK)
Barclays Analyst forecast on BMY
Emily Field
Barclays
Barclays
$75
Buy
15.88%
Upside
Reiterated
07/31/26
Barclays Sticks to Their Buy Rating for Bristol-Myers Squibb (BMY)
Cantor Fitzgerald Analyst forecast on BMY
Carter Gould
Cantor Fitzgerald
Cantor Fitzgerald
$59
Hold
-8.84%
Downside
Reiterated
07/30/26
Bristol-Myers Squibb (BMY) Receives a Hold from Cantor Fitzgerald
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bristol-Myers Squibb

3 Months
Srikripa DevarakondaTruist Financial
Success Rate
12/16 ratings generated profit
75%
Average Return
+9.79%
reiterated a buy rating 9 days ago
Copying Srikripa Devarakonda's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +9.79% per trade.
1 Year
David AmsellemPiper Sandler
Success Rate
11/11 ratings generated profit
100%
Average Return
+25.07%
assigned a buy rating 12 days ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.07% per trade.
2 Years
David AmsellemPiper Sandler
Success Rate
11/11 ratings generated profit
100%
Average Return
+29.62%
assigned a buy rating 12 days ago
Copying David Amsellem's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +29.62% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BMY Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
21
22
27
49
41
Hold
36
38
35
38
29
Sell
1
1
1
2
1
Strong Sell
0
0
0
0
0
total
58
61
63
89
71
In the current month, BMY has received 41 Buy Ratings, 29 Hold Ratings, and 1 Sell Ratings. BMY average Analyst price target in the past 3 months is 66.30.
Each month's total comprises the sum of three months' worth of ratings.

BMY Financial Forecast

BMY Earnings Forecast

Next quarter’s earnings estimate for BMY is $1.72 with a range of $1.57 to $1.92. The previous quarter’s EPS was $2.04. BMY beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.44% of the time in the same period. In the last calendar year BMY has Outperformed its overall industry.
Next quarter’s earnings estimate for BMY is $1.72 with a range of $1.57 to $1.92. The previous quarter’s EPS was $2.04. BMY beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.44% of the time in the same period. In the last calendar year BMY has Outperformed its overall industry.

BMY Sales Forecast

Next quarter’s sales forecast for BMY is $12.59B with a range of $11.94B to $13.06B. The previous quarter’s sales results were $12.98B. BMY beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.26% of the time in the same period. In the last calendar year BMY has Outperformed its overall industry.
Next quarter’s sales forecast for BMY is $12.59B with a range of $11.94B to $13.06B. The previous quarter’s sales results were $12.98B. BMY beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.26% of the time in the same period. In the last calendar year BMY has Outperformed its overall industry.

BMY Stock Forecast FAQ

What is BMY’s average 12-month price target, according to analysts?
Based on analyst ratings, Bristol-Myers Squibb’s 12-month average price target is 66.30.
    What is BMY’s upside potential, based on the analysts’ average price target?
    Bristol-Myers Squibb has 2.44% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BMY a Buy, Sell or Hold?
          Bristol-Myers Squibb has a consensus rating of Moderate Buy which is based on 9 buy ratings, 11 hold ratings and 1 sell ratings.
            What is Bristol-Myers Squibb’s price target?
            The average price target for Bristol-Myers Squibb is 66.30. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $80.00 ,the lowest forecast is $40.00. The average price target represents 2.44% Increase from the current price of $64.72.
              What do analysts say about Bristol-Myers Squibb?
              Bristol-Myers Squibb’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Streets Analysts.
                How can I buy shares of BMY?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.